RxDoctor Payments Data

Nathaniel Richards, MD

Hospitalist · Seneca, SCNPI 1700171618

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $579 of the $950 with a category attached, or 61.0%. Intuitive Surgical accounts for 61.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $579 and has fallen 96.2% since, to $22 in 2025. Among hospitalist clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$950in general payments, 2019–2025

Across 16 payments — averaging $59.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$579
  • Johnson & Johnson$146
  • Genentech USA, Inc.$109
  • E.r. Squibb & Sons, L.L.C.$31
  • Novartis$26
  • Amgen$25
  • plus $34 from 2 others

What the payments were for

  • Travel & lodging$57961%
  • Food & beverage$37039%

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$950 in reported general payments places this provider in the 90th percentile of 398 hospitalist providers in South Carolina.

See all hospitalist providers in South Carolina

Medicare billing

Part B allowed, 2024
$68,139
Medicare patients
270
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin13$13,740
Atorvastatin Calcium35$413
Amlodipine Besylate11$172
Cefdinir15$96
Prednisone21$76
Lisinopril13$43
Doxycycline Hyclate11$37
Furosemide13$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$22$13,74013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 398 hospitalist providers in South Carolina.

Other hospitalist in Seneca

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →